Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine vs Adefovir in LC-B
NCT00672867Phase 3Completed
- Sponsor
- Bukwang Pharmaceutical
- Start
- Dec 2007
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevudine in hepatitis B (HBV), Liver cirrhosis (LC), sponsored by Bukwang Pharmaceutical. Started Dec 2007; status: completed.
02
Drugs
clevudine
03
Conditions
hepatitis B (HBV)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT00672867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672867.